A uniquely positive, self-described patient experience with the R-MAOI Moclobemide, prescribed for treatment-resistant-depression-anxiety.

Autor: Adams NN; Robert Gordon University, Aberdeen, Scotland. Electronic address: n.adams5@rgu.ac.uk.

Publikováno v: Psychiatry research [Psychiatry Res] 2024 Jul; Vol. 337, pp. 115924. Date of Electronic Publication: 2024 Apr 25.

Identification of the exosomal PD-L1 inhibitor to promote the PD-1 targeting therapy of gastric cancer.

Autor: Sun JG; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Gao Y; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Drug Discovery and Development, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Henan, 450052, Zhengzhou, China., Gao YS; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: gaoys@zzu.edu.cn., Dai XJ; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Drug Discovery and Development, School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Henan, 450052, Zhengzhou, China. Electronic address: dxj@zzu.edu.cn., Chen P; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Electronic address: chenpengde220@163.com.

Publikováno v: European journal of medicinal chemistry [Eur J Med Chem] 2024 Mar 15; Vol. 268, pp. 116182. Date of Electronic Publication: 2024 Feb 07.

Remission from severe treatment-resistant depression with moclobemide: A case report.

Autor: Lafrenière S; Department of Psychiatry and Neurosciences, Université Laval, 2325, rue de l'université, Québec, QC G1V 0A6, Canada. Electronic address: Simon.lafreniere.2@ulaval.ca., Blier P; The Royal's Institute of Mental Health Research, 1145, Carling Avenue, Ottawa, ON, K1Z 7K4, Canada; Department of Psychiatry, University of Ottawa, 1145, Carling Avenue, Ottawa, ON, K1Z 7K4, Canada; Department of Cellular and Molecular Medicine, University of Ottawa, 451, Smyth Road, Ottawa, ON, K1H 8M5, Canada.

Publikováno v: L'Encephale [Encephale] 2023 Dec; Vol. 49 (6), pp. 649-650. Date of Electronic Publication: 2023 Apr 21.

Administration of moclobemide facilitates fear extinction and attenuates anxiety-like behaviors by regulating synaptic-associated proteins in a rat model of post-traumatic stress disorder.

Autor: Xiao B; Basic Medical Sciences College, China Medical University, Shenyang, China., Han F; Basic Medical Sciences College, China Medical University, Shenyang, China., Shi Y; Basic Medical Sciences College, China Medical University, Shenyang, China.

Publikováno v: Synapse (New York, N.Y.) [Synapse] 2020 Jun; Vol. 74 (6), pp. e22146. Date of Electronic Publication: 2020 Feb 17.

Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice.

Autor: Poleszak E; Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland. ewa.poleszak@umlub.pl., Wośko S; Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland., Sławińska K; Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland., Wyska E; Department of Pharmacokinetics and Physical Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland., Szopa A; Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland., Świąder K; Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland., Wróbel A; Second Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, 20-090, Lublin, Poland., Szponar J; Toxicology Clinic, Medical University of Lublin: Clinical Department of Toxicology and Cardiology, Stefan Wyszyński Regional Specialist Hospital in Lublin, Al. Kraśnicka 100, Lublin, Poland., Doboszewska U; Department of Animal Physiology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19, 20-033, Lublin, Poland., Wlaź P; Department of Animal Physiology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19, 20-033, Lublin, Poland., Wlaź A; Department of Pathophysiology, Medical University of Lublin, Jaczewskiego 8, 20-090, Lublin, Poland., Serefko A; Laboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland. anna.serefko@umlub.pl.

Publikováno v: Pharmacological reports : PR [Pharmacol Rep] 2020 Dec; Vol. 72 (6), pp. 1562-1572. Date of Electronic Publication: 2020 Mar 27.